3.0.0 1407 2026-02-23T21:55:31Z 2026-02-23T21:55:31Z Senate S S 2025-04-10 119 https://www.congress.gov/bill/119th-congress/senate-bill/1407 ssfi00 Finance Committee Senate Standing Referred To 2025-04-10T15:46:10Z 2025-04-10 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2025-04-10 Introduced in Senate IntroReferral 10000 9 Library of Congress C001095 Sen. Cotton, Tom [R-AR] Tom Cotton R AR N Health Health 2025-05-09T12:45:58Z 00 2025-04-10 Introduced in Senate 2026-02-23T21:53:34Z Anyone But China Safe Drug Act or the ABC Safe Drug Act

This bill restricts federal health care programs from purchasing drugs with active ingredients manufactured in China and provides tax incentives for the purchase of certain pharmaceutical and device manufacturing property for use in the United States.

The bill phases in restrictions on federal health care programs’ purchase of drugs. By January 1, 2030, federal health care programs may not purchase any drug that contains active ingredients from China or countries that do not meet the health and safety standards of the Food and Drug Administration. The Department of Health and Human Services may issue a waiver for an agency or program that is unable to meet this requirement; this waiver authority expires in 2031.

The bill also requires all drugs to be labeled with the country of origin of each active ingredient in the drug. Drugs that are not labeled with this information are deemed misbranded.

Finally, the bill allows 100% tax expensing for qualified pharmaceutical and medical device manufacturing property placed in service between 2025 and 2030. Qualified pharmaceutical and medical device manufacturing property is any tangible property placed in service in the United States as part of the construction or expansion of property for the manufacture of drugs or devices.

]]> ABC Safe Drug Act Display Title 45 ABC Safe Drug Act 2025-05-01T02:23:17Z Short Title(s) as Introduced 101 ABC Safe Drug Act 2025-05-01T02:23:16Z Introduced in Senate IS Short Title(s) as Introduced 101 Anyone But China Safe Drug Act 2025-05-01T02:23:16Z Introduced in Senate IS Official Title as Introduced 6 A bill to ban the use of Federal funds for the purchase of drugs manufactured in the People's Republic of China, and for other purposes. 2025-05-01T02:18:21Z Introduced in Senate IS Introduced in Senate 2025-04-10T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-119s1407is/xml/BILLS-119s1407is.xml 2025-04-10 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.